Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | CTSL | P07711 | 2/20 | 0.33 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSG | P08311 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2189182 | 1.00 | TSHR (0.45) | TSHRHSP90B1LMNAPPM1BPTPN1 | |
| SCHEMBL28833013 | 0.98 | TSHR (0.44) | TSHRHSP90B1LMNAPPM1BPTPN1 | |
| SCHEMBL29981924 | 0.98 | TSHR (0.46) | TSHRHSP90B1LMNAPPM1BPTPN1 | |
| SCHEMBL6666772 | 0.85 | PPM1B (0.41) | TSHRHSP90B1PPM1BPTPN1PPP1CC | |
| SCHEMBL28475631 | 0.82 | LGALS3 (0.33) | — | |
| SCHEMBL14317077 | 0.82 | AHCY (0.45) | TSHRLMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL27766467 | 0.82 | AHCY (0.45) | TSHRLMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL27737603 | 0.81 | LGALS3 (0.46) | TSHRHSP90B1LMNAPPM1BPTPN1 | |
| SCHEMBL28214269 | 0.81 | AHCY (0.34) | HSP90B1 | |
| SCHEMBL4101557 | 0.80 | POLB (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117567636-A | Anti-ethyl glucuronic acid monoclonal antibody, application and product thereof | 杭州旭科生物技术有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117502321-A | Method for screening apocynum venetum oxytocin and application of oxytocin | 滨州市海洋发展研究院 | 2024-02-06 | — | — | CN | claimed |
| CN-112198235-A | Method for detecting ethyl sulfate and ethyl glucuronate in human urine | 复旦大学 | 2021-01-08 | — | — | CN | claimed |
| CN-107664664-B | Method for simultaneously detecting 4-class ethanol non-oxidized metabolites in human whole blood | 复旦大学 | 2020-09-01 | — | — | CN | claimed |
| CN-110658268-A | Method for simultaneously detecting multiple ethanol non-oxidized metabolites in blood spots | 复旦大学 | 2020-01-07 | — | — | CN | claimed |
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-119355251-A | Identification mark for accurately distinguishing drinking death from post-death wine filling and identification method thereof | 山西医科大学 | 2025-01-24 | — | — | CN | disclosed |
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-09 | — | — | US | disclosed |
| WO-2025006991-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-02 | — | — | WO | disclosed |
| CN-117502321-B | Method for screening apocynum venetum oxytocin and application of oxytocin | 滨州市海洋发展研究院 | 2024-11-15 | — | — | CN | disclosed |
| CN-117502321-B | Method for screening apocynum venetum oxytocin and application of oxytocin | 滨州市海洋发展研究院 | 2024-11-15 | — | — | CN | disclosed |
| EP-4157853-B1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC (CA) | 2024-07-31 | — | — | EP | disclosed |
| EP-1358255-A1 | POROUS POLYMERS | Polymerat Pty Ltd (AU) | 2003-11-05 | — | — | EP | disclosed |
| WO-2003040218-A1 | POROUS POLYMER FILMS | POLYMERAT PTY LTD (AU) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003002545-A1 | PEPTOID COMPOUNDS | UNIVERSITY OF WOLLONGONG (AU) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002050174-A1 | POROUS POLYMERS | POLYMERAT PTY LTD (AU) | 2002-06-27 | — | — | WO | disclosed |
| EP-0831767-A4 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0831767-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | Yu, Ruey J., Dr. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5686489-A | TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996040047-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | EBP, ADH1A, ADH1C | TSHR 3405/4885HSP90B1 2317/4885LMNA 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.